Evidence map›Paper›PMID 27044909›Full record

ArticleBioarchitecture2016

Ankyrin-B in lens architecture and biomechanics: Just not tethering but more.

Ponugoti Vasantha Rao, Rupalatha Maddala

Open access · bronzeAbstract readComment
In one paragraph

Article in Bioarchitecture, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Microtubules: Evolving roles and critical cellular interactions.Experimental biology and medicine (Maywood, N.J.) · 2019
    Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ponugoti Vasantha Raoa Department of Ophthalmology , Duke University School of Medicine , Durham , NC , USA.
Rupalatha Maddalaa Department of Ophthalmology , Duke University School of Medicine , Durham , NC , USA.
Duke University · US

Funding

VISION RESEARCHP30EY005722 · NEI · DUKE UNIVERSITY · PI Vadim Y Arshavsky · 1985 to 2026
$19.3M
Trabecular Meshwork Cytoskeletal Signaling-Regulation of Aqueous Humor OutflowR01EY018590 · NEI · DUKE UNIVERSITY · PI RAO, P VASANTHA · 2008 to 2022
$5.6M
Fiber Cell Membrane Organization-Role in Lens Architecture and FunctionR01EY025096 · NEI · DUKE UNIVERSITY · PI RAO, P VASANTHA · 2015 to 2019
$2.0M
NEI NIH HHS P30 EY005722NEI NIH HHS R01EY018590NEI NIH HHS R01 EY025096NEI NIH HHS R01EY025096
6 · The paper itself

Abstract

The ankyrins are a family of well-characterized metazoan adaptor proteins that play a key role in linking various membrane-spanning proteins to the underlying spectrin-actin cytoskeleton; a mechanistic understanding of their role in tissue architecture and mechanics, however, remains elusive. Here we comment on a recent study demonstrating a key role for ankyrin-B in maintaining the hexagonal shape and radial alignment of ocular lens fiber cells by regulating the membrane organization of periaxin, dystrophins/dystroglycan, NrCAM and spectrin-actin network of proteins, and revealing that ankyrin-B deficiency impairs fiber cell shape and mechanical properties of the ocular lens. These observations indicate that ankyrin-B plays an important role in maintaining tissue cytoarchitecture, cell shape and biomechanical properties via engaging in key protein: protein interactions required for membrane anchoring and organization of the spectrin-actin skeleton, scaffolding proteins and cell adhesive proteins.

Indexed as

AnimalsAnkyrinsEpithelial CellsLens, CrystallineMembrane ProteinsAnkyrinsMembrane Proteinsankyrin-Bbiomechanicscell shapecytoarchitecturelens fibersmembrane organization

Identifiers

PMID27044909
PMCPMC4914019
OpenAlexW2317461997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.